Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × famitinib × Clear all

Phase

Phase 2 3 Phase 3 1

Status

Terminated 4 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cisplatin 87 Carboplatin 83 pembrolizumab 81 Gemcitabine 69 Paclitaxel 67 Docetaxel 63 Capecitabine 48 Oxaliplatin 46 Fluorouracil 46 Specimen Handling 44 Radiotherapy 44 Magnetic Resonance Spectroscopy 41 Bevacizumab 41 Cyclophosphamide 37 Dexamethasone 36 Pemetrexed 35 Drug Therapy 35 Leucovorin 34 Doxorubicin 32 Irinotecan 30 Rituximab 27 Injections 26 Lenalidomide 25 Vincristine 24 Trastuzumab 24 Radiosurgery 22 Radiation 22 toripalimab 21 Prednisone 21 Etoposide 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05999149 2024-02-21

BCTOP-T-N01

Fudan University

Phase 3 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡